SCM
PFE icon

Seamans Capital Management’s Pfizer PFE Stock Holding History

Seamans Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$50.3K Hold
1,686
– – 0.17% 51
2015
Q2 		$53.6K Hold
1,686
– – 0.13% 54
2015
Q1 		$56K Hold
1,686
– – 0.13% 55
2014
Q4 		$50K Hold
1,686
– – 0.12% 54
2014
Q3 		$47K Hold
1,686
– – 0.08% 55
2014
Q2 		$47K Sell
1,686
-844
-33% -$24.1K 0.07% 63
2014
Q1 		$77K Buy
+2,530
New +$75.4K 0.1% 55

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Seamans Capital Management's PFE Position: Q3 2015 in Review

Seamans Capital Management held its Pfizer (PFE) position steady in Q3 2015 at 1,686 shares worth $50.3K. The position accounts for 0.17% of the portfolio, ranked #51.

Seamans Capital Management first reported a position in PFE in Q1 2014 and has held it in 7 quarters since. The position peaked at $77K in Q1 2014. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

  • Seamans Capital Management held 1,686 shares of Pfizer worth $50.3K as of Q3 2015.
  • Seamans Capital Management left its Pfizer share count unchanged in Q3 2015.
  • Pfizer made up 0.17% of Seamans Capital Management's portfolio in Q3 2015, its #51 holding.
  • Seamans Capital Management first reported a position in Pfizer in Q1 2014 and has held it in 7 quarters since.
  • Seamans Capital Management's Pfizer position peaked at $77K in Q1 2014.
  • 1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Seamans Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.